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S U M M A R Y
Background: Methicillin is the drug of choice to treat infections caused by resistant strains of
Staphylococcus aureus. However, methicillin-resistant S. aureus (MRSA) is now becoming endemic in
many hospitals worldwide and is the cause of nosocomial outbreaks.
Methods: To assess clonality and dissemination of MRSA strains in the hospitals of Tehran, a total of 60
MRSA strains were isolated from hospitalized patients (n = 44) and hospital equipment and environment
(n = 16) of three metropolitan hospitals in Tehran between July 2009 and March 2010. These strains were
subjected to antimicrobial susceptibility testing, pulsed-ﬁeld gel electrophoresis (PFGE), and
biochemical ﬁngerprinting using the PhPlate system.
Results: Results showed the presence of between one and three dominant clonal groups within each
hospital, with most equipment and environmental strains being identical to the dominant clones of
hospitalized patient strains. The rate of resistance of these strains to the 13 antibiotics tested ranging
from 2% to 100%, with resistance being highest for penicillin, ciproﬂoxacin, and tetracycline (>98% of the
isolates). Comparison of the strains isolated from the three hospitals using a combination of PFGE and
PhP types showed the presence of 11 clonal groups of MRSA among these hospitals; of these, three
common clonal groups also had identical antibiotic resistance patterns and were found in more than one
hospital.
Conclusions: These data suggest dissemination of a few dominant clonal groups of MRSA strains in
hospitals in Tehran, with high level resistance to other commonly used antibiotics.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Staphylococcus aureus is one of the leading etiologic agents of
hospital-acquired (HA) and community-acquired (CA) infections.1
Staphylococcal diseases range from minor infections of the skin to
postoperative wound infections, bacteremia, infections associated
with foreign bodies, and necrotizing pneumonia.2,3 Methicillin-
resistant strains of S. aureus (MRSA) have been reported to be
endemic in many hospitals throughout the world, and particularly
affect patients in the intensive care unit (ICU) and those who have
undergone major surgery.4,5* Corresponding authors. Tel.: +98 21 66405534.
E-mail addresses: Lari@tums.ac.ir (A. Rastegar Lari), pour@pasteur.ac.ir
(M.R. Pourshaﬁe).
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http://dx.doi.org/10.1016/j.ijid.2013.01.032The uncontrolled use of antibiotics is often seen as part of the
cause of the growing resistance of bacteria to antibiotics, and the
persistence and spread of resistant bacteria in hospitals is of major
concern to physicians treating patients.6 In the acute care setting,
patients spend a substantial amount of time in hospital beds
surrounded by a variety of equipment, devices, and environmental
surfaces that can potentially harbor bacteria. These bacteria may
be transmitted to the patients either through direct contact or via
the hands of healthcare workers.7
Despite the efforts made to control hospital infections, there is
growing evidence that the incidence of nosocomial MRSA
transmission is continuing to rise throughout the world. This
highlights the need for appropriate interventions to optimize the
effectiveness of MRSA infection control strategies.8 In this respect,
many reports have addressed the phenotypic and genotypic
diversity of MRSA, which will allow us to monitor the dissemina-
tion of these strains, which may in turn facilitate their control.9ses. Published by Elsevier Ltd. All rights reserved.
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(PFGE) has been recorded as the gold standard method for
monitoring the epidemiology of MRSA in hospitals and the
community.10 Of the phenotypic methods used to characterize
nosocomial strains of MRSA, the PhenePlate (PhP) technique has
been suggested as a simple and rapid typing method for testing a
high number of MRSA strains for such studies.11
In view of the importance of the MRSA strains in clinical settings
and their growing resistance to a number of antibiotics, this study
was undertaken to investigate the prevalence and spread of MRSA
strains isolated from patients and the hospital environment in
Tehran, Iran.
2. Patients and methods
2.1. Sampling, isolation, and identiﬁcation of MRSA strains
Between July 2009 and March 2010, a total of 324 clinical
isolates of S. aureus were collected from hospitalized patients in
three metropolitan hospitals, Feriozgar Hospital (FH, 46 isolates),
Shirati Hospital (SH, 217 isolates), and Aliasgar Hospital (AAH, 61
isolates), located in different parts of Tehran, Iran. During the same
period, a total of 1181 specimens were also collected from the
medical instruments within these hospitals by monthly sampling
and were tested for the presence of MRSA. The samples were taken
from equipment including oxygen pumps and masks, suction
devices, radiology apparatus, ventilators and connection tubes,
catheters, monitoring devices, respirators, nasogastric tubes,
stethoscopes, cardio-shock devices, and serum stands. Samples
were also taken from patient rooms, including televisions and TV
control handsets, chairs, desks, curtains, trash cans, computers,
weighing machines, baskets for collecting sheets, toilet sinks,
chests and drawers, bed sheets, doors and door handles, beds,
partitions, patient slippers, refrigerators, drinking water sets,
walls, and ﬂoors. The hospital equipment and environment
samples were collected using sterile swabs and transported to
the laboratory in sterile normal saline, where they were cultured in
thioglycolate broth and incubated at 37 8C for 24 h, after which
they were cultured on Baird–Parker agar plates and incubated at
37 8C for 24–48 h.
All clinical samples were initially searched for the presence of S.
aureus in the pathology laboratory of each hospital using Baird–
Parker agar plates and an incubation at 37 8C for 24 h. These
samples were also transported to the laboratory and sub-cultured
for purity before further testing.
2.2. PCR
Suspected S. aureus isolates were subjected to standard
biochemical tests and were conﬁrmed by PCR using species-
speciﬁc primers to amplify the nucC gene. The primer sets were F
50AATTAATGTACAAAGGTCAAC30 and R 50TGATAAATATGG
ACGTGGCT30. The conﬁrmed S. aureus isolates were further tested
for the presence of the mecA gene: F 50GTAGAAATGACT
GAACGTCCGATAA30 and R 50CCAATTCCACATTGTTTCGGTCTAA30.12
12 The reaction mixture contained 10 PCR buffer, Taq DNA
polymerase (0.5 U) (HT Biotechnology, Cambridge, UK), each
primer (1.6 mM), MgCl2 (1.2 mM), each dNTP (0.64 mM), and 10 ml
of puriﬁed bacterial DNA. The PCR for ampliﬁcation of the nucC
gene was performed under the following conditions: denaturation
for 3 min at 94 8C; 35 cycles of 30 s at 94 8C, 30 s at 56 8C, and 30 s at
72 8C; and a ﬁnal extension step of 5 min at 72 8C. Conﬁrmation of
the methicillin-resistant isolates was done after an initial
susceptibility test against oxacillin followed by ampliﬁcation of
the mecA gene under the following conditions: denaturation for5 min at 94 8C; 30 cycles of 15 s at 94 8C, 15 s at 61 8C, and 30 s at
72 8C; and a ﬁnal extension step of 2 min at 72 8C.
2.3. In vitro susceptibility tests
Using the methods of the Clinical and Laboratory Standard
Institute (CLSI),13 all clinical isolates were tested for their resistance
to 13 antimicrobial agents using the following antimicrobial
impregnated disks (Mast Diagnostics Ltd, Bootle, Merseyside, UK):
oxacillin (OX) (1 mg), penicillin (P) (10 U), erythromycin (E) (15 mg),
ciproﬂoxacin (CIP) (5 mg), gentamicin (GM) (120 mg), chloramphen-
icol (C) (30 mg), rifampin (RA) (5 mg), co-trimoxazole (SXT) (25 mg),
tetracycline (T) (30 mg), clindamycin (CD) (2 mg), quinupristin/
dalfopristin (SYN) (15 mg), vancomycin (V) (30 mg), and linezolid
(LZD) (30 mg). The minimum inhibitory concentration (MIC) of the
bacterial isolates resistant to oxacillin was measured using E-test
strips (Biodisk AB, Solna, Sweden).
2.4. Typing of MRSA isolates
All isolated MRSA were typed using PFGE and a high-resolution
biochemical ﬁngerprinting method, i.e., PhPlate CS plates, which
are speciﬁcally developed for the typing of Staphylococcus strains
(PhPlate AB, Stockholm, Sweden). The PhenePlate system is based
on the evaluation of the kinetics of biochemical reactions,
performed in liquid medium in 96-well microplates.13 In brief, a
loopful of a fresh bacterial culture was inoculated in 10 ml of
PhPlate growth medium containing 0.2% (w/v) proteose peptone,
0.05% (w/v) yeast extract, 0.5% (w/v) NaCl, and 0.011% (w/v)
bromothymol blue, and aliquots of 175 ml of each bacterial
suspension were inoculated into the 24 wells of each set with the
aid of a multichannel pipette. The plates were then incubated at
37 8C and images of the plates were scanned after 16, 24, and 48 h
using an HP Scanjet 4890 scanner. After the ﬁnal scan, the PhPlate
software (PhPWin 4.2) was used to create absorbance data
(biochemical ﬁngerprint) from the scanned images, in accordance
with the manufacturer’s instructions. Similarity among the isolates
was calculated as the correlation coefﬁcient after a pair-wise
comparison of the biochemical ﬁngerprints and clustered accord-
ing to the unweighted pair group method (UPGMA) with
arithmetic averages.14
For PFGE, a single and well-isolated colony grown on blood agar
was inoculated into 10 ml of tryptic soy broth (TSB) and grown on a
reciprocal shaker at 37 8C overnight. A bacterial suspension with
150 ml EC buffer (100 mM EDTA, 1 M NaCl, 6 mM Tris-Hcl, 0.2%
deoxycholate, 0.5% sodium lauroyl sarcosine, 0.5% Brij-58) contain-
ing 20 ml lysostaphin (20 mg/ml) was added to 150 ml molten
agarose gel and placed in plug molds. The plugs were treated
overnight at 37 8C with lysing buffer containing lysozyme (1 mg/
ml) and 5 mg of RNase per ml to lysis buffer (6 mM Tris (pH 7.5),
1 M NaCl, 100 mM ethylenediaminetetraacetic acid (EDTA; pH
7.5), 0.5% Brij-58, 0.2% sodium deoxycholate, and 1% sodium lauryl
sarcosine). After digestion with 20 U SmaI (Roche, Manheim,
Germany), the plugs were placed in the wells of 1% agarose in 0.5%
TBE (Tris/Borate/EDTA) and electrophoresed with switch times
ramped from 5 s to 35 s at 6 V with a run time of 24 h at 16 8C in a
Bio-Rad CHEF-DRII system. The banding patterns were clustered
by the UPGMA method using the software Gelcompare II version
4.0 (Applied Maths, Sint-Martens-Latem, Belgium).
3. Results
3.1. Bacterial isolates
In all, 324 strains of S. aureus were isolated from the clinical
cases in all three hospitals. Of these, 44 strains (13.6%) were shown
Table 1
Number of MRSA strains found in each of the three hospitals in Tehran. The percentage of MRSA strains in each hospital has been calculated based on the total number of
clinical or environmental MRSA strains obtained from all three hospitals
Sources of isolates or samples No. of MRSA isolates in each hospital Total
SH (%) FH (%) AAH (%)
Clinical samples 33 (75.6) 2 (4.4) 9 (20.0) 44
Lung secretion 12 (35.3) 2 (100) 3 (33.3) 17
Wound 9 (26.5) 0 0 9
Blood 10 (29.4) 0 0 10
Other 2 (9.1) 0 6 (66.7) 8
Hospital environment or equipment 6 (37.5) 7 (43.7) 3 (18.8) 16
Equipment
Oxygen mask 3 (50.0) 3 (42.9) 0 6
Ventilator tube 1 (16.7) 0 2 (66.7) 3
Other 0 2 (28.6) 1 (33.3) 3
Hospital environment
Bed 1 (16.7) 2 (28.6) 0 3
Drinking water set 1 (16.7) 0 0 1
Hospital wards
ICUs 5 5 3 13
CCU 0 1 0 1
Surgical ward 1 1 0 2
MRSA, methicillin-resistant Staphylococcus aureus; SH, Shirati Hospital; FH, Feriozgar Hospital; AAH, Aliasgar Hospital; ICU, intensive care unit; CCU, Coronary Care Unit.
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(n = 21), neonatal ICU (n = 4), kidney (n = 3), blood (n = 5), surgery
(n = 2), pulmonary (n = 2), labor (n = 1), and orthopedic (n = 2)
wards; for four isolates the location was not deﬁned. The most
common sources of MRSA isolates were found to be lung secretion
(n = 17), blood (n = 10), and wound infections (n = 9), constituting
71% of the collected MRSA in these hospitals. Other sources
included body ﬂuid (n = 3), eye infection (n = 3), urine (n = 1), and
pharyngeal infection (n = 1) (Table 1).
Among the 1181 specimens collected from medical instruments
and the hospital environment in all three hospitals, 16 MRSA
strains (1.3%) were isolated. Of these, the majority of the strains
were isolated from oxygen masks (n = 6) and ventilators or
ventilator tubes (n = 3), nasogastric tube (n = 1), suction device
(n = 1), serum tube (n = 1), patient beds (n = 3), and drinking water
fountain (n = 1) (Table 1).
3.2. Antibiotic resistance of MRSA strains
All clinical isolates were susceptible to linezolid, vancomycin,
and quinupristin/dalfopristin. However, they showed different
degrees of resistance to other antibiotics (ranging from 2% to
100%), with the highest resistance shown to penicillin, ciproﬂoxa-
cin, and tetracycline (>98%). Almost the same pattern of antibiotic
resistance was observed among the MRSA isolates from equipment
and the hospital environment, with the exception that the isolates
from the latter group were susceptible to chloramphenicol (Figure
1). It was also found that the clinical and equipment and
environment isolates had a MIC 256 mg/ml for oxacillin. Amongst
the isolates, two clinical strains showed MICs of 3 mg/ml and
12 mg/ml.
3.3. Clonality of the MRSA strains
According to the PhP typing method, the MRSA strains belonged
to six common types (CT1–CT6), constituting 47 (78%) isolates, and
13 single types (ST). CT1 and CT2 contained MRSA strains from
both patients and the hospital environment of all three hospitals
(Figure 1). Using the PFGE method, the MRSA strains were divided
into 14 pulsotypes made of ﬁve common pulsotypes, constituting
51 (85%) isolates, and nine single pulsotypes (Figure 1). Whilst
strains belonging to common PhP types or pulsotypes were found
in two of the three hospitals, certain pulsotypes (i.e. type A) werefound in all three hospitals. Clonal types A and C were found in
both clinical and equipment and environment samples. Equipment
and environment samples in these clonal types included oxygen
mask, ventilator, and bed set. Other isolates obtained from oxygen
mask and ventilator showed single PFGE types.
Combination of the PhP types, pulsotypes, and antibiotic
resistance patterns of the strains showed the presence of 10
common and 25 single types (i.e., C-types F1–F35) with some F
types containing strains from different wards (i.e., F27) or from
both patients and the equipment/hospital environment (i.e., F20)
(Figure 1).
4. Discussion
The three hospitals chosen for this study included a children’s
hospital, a mid-size metropolitan hospital, and a major metropoli-
tan hospital with extremely high referral rates; these were chosen
in order to obtain a better understanding of the prevalence of
MRSA strains in Tehran. Indeed, a high proportion of the clinical
strains (67%) were obtained from the major metropolitan hospital
(i.e., SH). Despite this, the ratio of MRSA over methicillin-sensitive
S. aureus (MSSA) strains in all three hospitals did not differ
signiﬁcantly (data not shown), indicating that the number of
patients is not the key determinant of the prevalence of clinical
cases of MRSA strains in each hospital. A similar pattern was also
observed with the equipment and environment strains of MRSA
that were regarded as resident in each hospital. An extensive
sampling from each hospital’s environment or instruments over a
period of 1 year, provided a high conﬁdence level that the presence
of environmental strains of MRSA was not overlooked in these
hospitals.
Using two high-resolution phenotypic and genotypic methods,
these environmental samples were then compared to those
isolated from clinical sources in different wards within each
hospital. The results indicated a strong link between these strains.
Of the isolates evaluated in this study from the three hospitals, 51
(85%) were found to have pulsotypes associated with inter-
hospital dissemination, as they were detected in more than one
hospital. Moreover, within each hospital, some strains were
isolated from different wards, i.e., pulsotypes A and C, indicating
intra-hospital transmission as well. Although phenotypes of MRSA
isolated from the environment are not always identical to those
affecting patients within a clinical setting, there have been several
Figure 1. PFGE analysis of MRSA strains isolated from hospitalized patients and the hospital environment in Tehran, Iran. E, erythromycin; CIP, ciproﬂoxacin; GM, gentamicin;
C, chloramphenicol; RP, rifampin; TS, co-trimoxazole; T, tetracycline; CD, clindamycin. CT1–CT6, common PhP types 1–6; CT1–ST13, PhP single, types 1–13.
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environmental source.15–17 These studies collectively indicate
that the environment and equipment found in a clinical setting
play a major role in sustaining endemic MRSA.15 Several other
studies have also indicated the prevalence of MRSA in the hospital
environment. Of these, few have explored speciﬁc aspects of the
environment such as faucet handles, door handles, computer
terminals, and bed handsets.18
In the present study, a wide range of ﬁxed and portable items
from the environment of each hospital was sampled and in mostcases the MRSA strains were identiﬁed on only a few items on
several sampling occasions. Interestingly, these items were located
either on the wards from which the clinical MRSA strains were
isolated or on equipment/instruments that were directly con-
nected to patients.
It has been established that a clonal relationship exists between
hospital equipment and patients infected with MRSA.19–21 In our
study similar equipment from different hospitals was found to
carry MRSA strains. For example, in AAH three MRSA strains were
isolated from ventilator tubes, two of which were in ICUs. Similar
S. Javidnia et al. / International Journal of Infectious Diseases 17 (2013) e691–e695 e695results were found in FH hospital, where the MRSA strains were
isolated from oxygen pump and oxygen mask in the ICU. The high
demand for the use of ICU facilities could be a reason for the high
prevalence of MRSA in these units, and/or the nature of the
ventilating tubes could enhance the accumulation of MRSA.
In this study we employed a high-resolution biochemical
ﬁngerprinting method (PhPlate system) and a high-resolution
genotypic method (PFGE) to compare the environmental and
clinical strains of MRSA within each hospital and between the
hospitals. In addition, we sought to identify clonal dissemination
within each hospital and the possible long term residency in these
clinical settings. Interestingly strains showing identical or highly
similar pulsotypes/PhP types also had identical or highly similar
antibiotic resistance patterns. On occasions, some strains with
identical PFGE or PhP patterns showed resistance to three or more
different antibiotics. Considering clonal dissemination of these
strains in different hospitals, such differences in antibiotic
resistance patterns could be due to different antibiotic treatment
regimes used in each hospital, or to the acquisition of resistance
genes by members of these clones after they were cross-
transmitted, or to their long residency periods in the hospital
environment, or a combination of these. This hypothesis, however,
has to be veriﬁed by analysis of antibiotic gene cassettes and the
order in which the resistance genes have been acquired by these
strains.
In conclusion, data obtained from the present study conﬁrmed
the presence of at least one clonal group of MRSA strains in each of
the three hospitals investigated. Through precise typing, these
strains were also shown to be found in the environment of the
same hospital and had highly similar antibiotic resistance patterns
to those isolated from patients. The fact that the majority of the
equipment and environment strains were isolated from instru-
ments on the same wards where the patients were infected,
suggests that they were the most probable source of infection.
However, there is a possibility that other sources of transmission
were also involved in these hospitals.
Findings from this study also showed that these strains could be
found in other hospitals, indicating the wide spread and cross-
transmission of a few clones of MRSA strains in these hospitals, and
probably other hospitals, in Tehran. In addition, effective and
regular cleaning and disinfection should be applied in order to
prevent environmental contamination and nosocomial infections.
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